Volume 28, Issue 1 (Avicenna Journal of Clinical Medicine-Spring 2021)                   Avicenna J Clin Med 2021, 28(1): 42-48 | Back to browse issues page


XML Persian Abstract Print


1- Assistant Professor, Department of Obstetrics and Gynecology, Baqiyatallah University of Medical Sciences, Tehran, Iran_Trauma Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
2- Medical Student, Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran
3- Assistant Professor, Department of Obstetrics and Gynecology, Baqiyatallah University of Medical Sciences, Tehran, Iran _Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran_Fetal Health Research Center, Hope Generation Foundation, Baqiyatallah University of Medical Sciences, Tehran, Iran , z.soleimanii2018@gmail.com
Abstract:   (2058 Views)
Background and Objective: Each type of cancer has its own histopathological findings that determine the type of treatment regimen and the course of the disease. The present study aimed to histopathologically determine the types of gynecological cancers in patients admitted to Baqiyatallah Hospital over a nine-year period.
Materials and Methods: This retrospective study was conducted based on hospital data of patients who were admitted to Baqiyatallah Hospital and underwent any procedure, treatment, and diagnosis of gynecologic cancers during 2011-2019. Patients' information was extracted from hospital integrated archiving system.
Results: A total of 404 patients were diagnosed with gynecological cancers between 2011 and 2019. Among these cancers, ovarian cancer with 212 (52.5%) patients was the most common gynecological cancer. Among patients with ovarian cancer, Serous Adenocarcinoma and Endometrioid Adenocarcinoma with 137 (64.6%) and 29 (13.7%) cases had the highest frequency of pathology, respectively. The mean (standard deviation) age of the patients with gynecological cancer was 55.88 (11.51) years. During the study period, there was a relatively increasing trend for ovarian cancer during 2011-19.
Conclusion: ovarian cancer with Serous Adenocarcinoma was the most common cancer diagnosed in patients admitted to Baqiyatallah Hospital during 2011-19. The relatively increasing trend of this type of female genital cancers during this 9-year period and the observed age pattern highlight the importance of implementing timely screening and treatment programs. 
 
 
Full-Text [PDF 922 kb]   (678 Downloads)    
Type of Study: Original | Subject: Obstetrics & Gynecology

References
1. Goli A, Oroei M, Jalalpour M, Faramarzi H, Askarian M. The spatial distribution of cancer incidence in fars province: a GIS-based analysis of cancer registry data. Int J Prev Med. 2013;4(10):1122–30. PMID: 24319551
2. Merletti F, Galassi C, Spadea T. The socioeconomic determinants of cancer. Environ Health. 2011;10(Suppl 1):S7. PMID: 21489217 DOI: 10.1186/1476-069X-10-S1-S7
3. Sadjadi A, Nouraie M, Mohagheghi M, Mousavi-Jarrahi A, Malekezadeh R, Parkin D. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev. 2005;6:359–63. PMID: 16236000
4. Babaei M, Mousavi S, Malek M, Tosi G, Masoumeh Z, Danaei N, et al. Cancer occurrence in Semnan Province, Iran: Results of a population-based cancer registry. Asian Pac J Cancer Prev. 2005;6(2):159-64. PMID: 16101326
5. Cramb S, Mengersen K, Baade P. Developing the atlas of cancer in Queensland: methodological issues. Int J Health Geogr. 2011;10:9. PMID: 21261992 DOI: 10.1186/1476-072X-10-9
6. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2011;20(3):556-63. DOI: 10.1093/annonc/mdn642
7. Masoompour S, Yarmohammadi H, Rezaianzadeh A, Lankarani K. Cancer incidence in southern Iran, 1998-2002: Results of population-based cancer registry. Cancer Epidemiol. 2011;35(5):e42-7. PMID: 21840285 DOI: 10.1016/j.canep.2011.05.018
8. Mehrabani D, Tabei SZ, Heydari ST, Shamsina SJ, Shokrpour N, Amini M, et al. Cancer occurrence in Fars Province, Southern Iran. Iran Red Crescent Med J. 2008;10(4):314-22.
9. Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev. 2017;26(4):444-57. PMID: 28223433 DOI: 10.1158/1055-9965.EPI-16-0858
10. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006;20(2):207-25. PMID: 16359925 DOI: 10.1016/j.bpobgyn.2005.10.007
11. Rajai N, Ghanbari A, Yoosefi M, Mohebi F, Mohajer B, Sheidaei A, et al. National and subnational trends in incidence and mortality of lung cancer in Iran from 1990 to 2016. Asia Pac J Clin Oncol. 2020;16(3):129-36. PMID: 32030897 DOI: 10.1111/ajco.13303
12. Razi S, Salehiniya H, Fathali Loy Dizaji M. Epidemiology of prevalent cancer among Iranian women and its incidence trends from 2003-2009 in Iran. J Arak Univ Med Sci. 2015; 18(2):17-24
13. Hoseini SS, Yousefi Z, Emadzadeh M, Homaee Shandiz F, Hokmabadi P, Salehi M, et al. Changes in prevalence and epidemiology of female genital cancers in northeastern Iran in a 35-year study. Iran J Obstet Gynecol Infertil. 2020;22(12):11-8.
14. Ansariniaki M, Ghorbani R, Semnani V, Pahlavan S. Epidemiological-histopathological status of gynecological cancers in Iranian population: a 9-year study. Koomesh. 2017;19(2):484-91.
15. Almasi-Hashiani A, Farahmand M. Trend of incidence rate for female genital cancers based on cancer registry data in Fars province during 2003-2009. J Feyz. 2012;16(4):353-60.
16. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020;8(2):e191-203. PMID: 31812369 DOI: 10.1016/S2214-109X(19)30482-6
17. Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169-82. PMID: 30638582 DOI: 10.1016/S0140-6736(18)32470-X
18. Dhakal HP, Pradhan M. Histological pattern of gynecological cancers. JNMA J Nepal Med Assoc. 2009;48(176):301-5. PMID: 21105554
19. Hailu HE, Mondul AM, Rozek LS, Geleta T. Descriptive epidemiology of breast and gynecological cancers among patients attending Saint Paul's Hospital Millennium Medical College, Ethiopia. PloS One. 2020;15(3):e0230625. PMID: 32196536 DOI: 10.1371/journal.pone.0230625
20. 20. Ibrahim H, Ijaiya MA. Pattern of gynaecological malignancies at the University of Ilorin Teaching Hospital, Ilorin, Nigeria. J Obstet Gynaecol. 2013;33(2):194-6. PMID: 23445148 DOI: 10.3109/01443615.2012.738717
21. Osinachi I, Adewole N, Isah A, Abdullahi H, Agida E. Pattern of gynaecological malignancies in a Nigerian tertiary hospital. Afr J Med Health Sci. 2020;19(3):29-35.
22. Jiang X, Tang H, Chen T. Epidemiology of gynecologic cancers in China. J Gynecol Oncol. 2018;29(1):e7. PMID: 29185265 DOI: 10.3802/jgo.2018.29.e7
23. Barman D, Sharma JD, Barmon D, Kataki AC, Sharma A, Kalita M. Epidemiology of gynecological cancers in Kamrup Urban District cancer registry. Indian J Cancer. 2017;54(1):388-91. PMID: 29199729 DOI: 10.4103/0019-509X.219590
24. Yamagami W, Nagase S, Takahashi F, Ino K, Hachisuga T, Aoki D et al. Clinical statistics of gynecologic cancers in Japan. J Gynecol Oncol. 2017;28(2):e32. PMID: 28198168 DOI: 10.3802/jgo.2017.28.e32
25. Lee SY, Kim E, Kim HS, Koo YJ, Lee DH. Clinical and histopathologic analysis of gynecological cancer: a single institute experience over 7 years. Yeungnam Univ J Med. 2020;37(3):179-85. PMID: 32131080 DOI: 10.12701/yujm.2019.00451

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.